Your browser doesn't support javascript.
loading
Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.
Ding, Chengchao; Patel, Darshit; Ma, Yunjing; Mann, Jamie F S; Wu, Jianjun; Gao, Yong.
Affiliation
  • Ding C; The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China.
  • Patel D; Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada.
  • Ma Y; Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada.
  • Mann JFS; Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada.
  • Wu J; Department of AIDS Research, Anhui Provincial Center for Disease Control and Prevention, Hefei, China.
  • Gao Y; The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China.
Front Immunol ; 12: 697683, 2021.
Article in En | MEDLINE | ID: mdl-34354709
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Antibodies / HIV Infections / HIV-1 / Broadly Neutralizing Antibodies Type of study: Systematic_reviews Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Antibodies / HIV Infections / HIV-1 / Broadly Neutralizing Antibodies Type of study: Systematic_reviews Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland